TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
New findings in tuberculosis described from Marmara University
September 23rd, 2008
"The first line anti-tuberculosis drugs isoniazid (INH), rifampicin (RIF) and pyrazinamide (PZA) continues to be the effective drugs in the treatment of tuberculosis, however, the use of these drugs is associated with toxic reactions in tissues, particularly in the liver, leading to hepatitis. Silymarin, a standard plant extract with strong antioxidant activity obtained from S. marianum, is known to be an effective agent for liver protection and liver regeneration," scientists writing in the journal Nutrition & Metabolism report. "The aim of this study was to investigate the protective actions of silymarin against hepatotoxicity caused by different combinations...
Source: TB & Outbreaks Week (2008-09-23)
|
